Nanobiotix (NASDAQ:NBTX) Shares Gap Up – Here’s Why

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX)’s share price gapped up before the market opened on Tuesday. The stock had previously closed at $31.53, but opened at $33.13. Nanobiotix shares last traded at $32.5090, with a volume of 14,517 shares.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Nanobiotix in a research note on Thursday, October 15th. Guggenheim began coverage on Nanobiotix in a report on Tuesday, September 15th. They issued a “buy” rating and a $64.00 price target for the company. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.67.

Nanobiotix Stock Performance

The firm’s fifty day simple moving average is $33.01 and its 200 day simple moving average is $33.60.

About Nanobiotix

Nanobiotix is a biotechnology company developing nanoparticle-based therapies designed to improve the effectiveness of radiotherapy in cancer treatment. The company’s technology uses hafnium oxide nanoparticles that are injected directly into a tumor and activated by ionizing radiation, with the goal of increasing energy deposition within cancer cells while limiting exposure to surrounding tissue.

Nanobiotix’s lead product candidate, NBTXR3, is being evaluated in clinical studies across several cancer types, including locally advanced head and neck cancer and other solid tumors.